Search Results - "Buolamwini, John K."
-
1
Integration of fingerprint-based similarity searching and kernel-based partial least squares analysis to predict inhibitory activity against CSK, HER2, JAK1, JAK2, and JAK3
Published in Molecular diversity (01-04-2024)“…Fingerprint-based similarity searching is an important strategy for virtual screening in drug discovery. In the present study, we carried out a systematic…”
Get full text
Journal Article -
2
A small-molecule inhibitor of MDMX activates p53 and induces apoptosis
Published in Molecular cancer therapeutics (01-01-2011)“…The p53 inactivation caused by aberrant expression of its major regulators (e.g., MDM2 and MDMX) contributes to the genesis of a large number of human cancers…”
Get full text
Journal Article -
3
The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models
Published in Nature communications (01-10-2014)“…A requirement for Mouse Double Minute 2 (MDM2) oncogene activation has been suggested to be associated with cancer progression and metastasis, including breast…”
Get full text
Journal Article -
4
Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors
Published in Bioorganic & medicinal chemistry (15-03-2011)“…HIV-1 integrase is one of the three most important enzymes required for viral replication and is therefore an attractive target for anti retroviral therapy. We…”
Get full text
Journal Article -
5
A novel RNA variant of human concentrative nucleoside transporter 1 (hCNT1) that is a potential cancer biomarker
Published in Experimental hematology & oncology (22-08-2019)“…The human concentrative nucleoside transporter 1 (hCNT1) a product of the gene is one of the three concentrative nucleoside transporters, with a substrate…”
Get full text
Journal Article -
6
Dipyridamole analogs as pharmacological inhibitors of equilibrative nucleoside transporters. Identification of novel potent and selective inhibitors of the adenosine transporter function of human equilibrative nucleoside transporter 4 (hENT4)
Published in Biochemical pharmacology (01-12-2013)“…To identify needed human equilibrative nucleoside transporter 4 (hENT4) inhibitors, we cloned and stably expressed the recombinant protein in PK15NTD…”
Get full text
Journal Article -
7
Inhibiting β-Catenin by β-Carboline-Type MDM2 Inhibitor for Pancreatic Cancer Therapy
Published in Frontiers in pharmacology (17-01-2018)“…The β-catenin and MDM2 oncoproteins are overexpressed and constitutively activated in human pancreatic cancer and contribute to its initiation, progression,…”
Get full text
Journal Article -
8
JKA97, a novel benzylidene analog of harmine, exerts anti-cancer effects by inducing G1 arrest, apoptosis, and p53-independent up-regulation of p21
Published in PloS one (27-04-2012)“…JKA97, a benzylidene analog of harmine, has been found to be a promising drug candidate for human cancer therapy, although the underlying molecular mechanisms…”
Get full text
Journal Article -
9
Synthesis and biological evaluation of novel 5( H)-phenanthridin-6-ones, 5( H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors
Published in Bioorganic & medicinal chemistry (01-02-2007)“…Substitution of β-diketo acid moiety onto the phenanthridinone and analogous polycyclic aromatic systems provided new potent HIV integrase (IN) inhibitors. The…”
Get full text
Journal Article -
10
Design, Synthesis, and Evaluation of 2-Diethanolamino-4,8-diheptamethyleneimino-2-(N-aminoethyl-N-ethanolamino)-6-(N,N-diethanolamino)pyrimido[5,4-d]pyrimidine-fluorescein Conjugate (8MDP-fluor), As a Novel Equilibrative Nucleoside Transporter Probe
Published in Bioconjugate chemistry (15-06-2011)“…Nucleoside transporters are integral membrane glycoproteins that play critical roles in physiological nucleoside and nucleobase fluxes, and influence the…”
Get full text
Journal Article -
11
Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action
Published in Cells (Basel, Switzerland) (01-07-2020)“…There is a desperate need for novel and efficacious chemotherapeutic strategies for human brain cancers. There are abundant molecular alterations along the p53…”
Get full text
Journal Article -
12
Synthesis and biological evaluation of phloridzin analogs as human concentrative nucleoside transporter 3 (hCNT3) inhibitors
Published in Bioorganic & medicinal chemistry letters (01-02-2009)“…The synthesis and [ 3H]-uridine uptake investigation of the structure–activity relationship of new phloridzin analogs at the human concentrative nucleoside…”
Get full text
Journal Article -
13
Anti-cancer Effects of JKA97 Are Associated with Its Induction of Cell Apoptosis via a Bax-dependent and p53-independent Pathway
Published in The Journal of biological chemistry (28-03-2008)“…p53, one of the most commonly mutated genes in human cancers, is thought to be associated with cancer development. Hence, screening and identifying natural or…”
Get full text
Journal Article -
14
Identification of the ENT1 Antagonists Dipyridamole and Dilazep as Amplifiers of Oncolytic Herpes Simplex Virus-1 Replication
Published in Cancer research (Chicago, Ill.) (15-05-2010)“…Oncolytic herpes simplex virus-1 (oHSV) vectors selectively replicate in tumor cells, where they kill through oncolysis while sparing normal cells. One of the…”
Get full text
Journal Article -
15
Small Molecule Induces Time‐Dependent Inhibition of Stat3 Dimerization and DNA‐Binding Activity and Regresses Human Breast Tumor Xenografts
Published in Chembiochem : a European journal of chemical biology (18-11-2024)“…Aberrantly‐active signal transducer and activator of transcription (Stat)3 has a causal role in many human cancers and represents a validated anticancer drug…”
Get full text
Journal Article -
16
SS-4 is a highly selective small molecule inhibitor of STAT3 tyrosine phosphorylation that potently inhibits GBM tumorigenesis in vitro and in vivo
Published in Cancer letters (01-05-2022)“…Glioblastoma (GBM) is a highly aggressive cancer with a dismal prognosis. Constitutively active STAT3 has a causal role in GBM progression and is associated…”
Get full text
Journal Article -
17
Targeting EGFR and HER-2 receptor tyrosine kinases for cancer drug discovery and development
Published in Medicinal research reviews (01-09-2006)“…Conventional anticancer therapy using cytotoxic drugs lacks selectivity and is prone to toxicity and drug resistance. Anticancer therapies targeting aberrant…”
Get full text
Journal Article -
18
Identification of a New Class of MDM2 Inhibitor That Inhibits Growth of Orthotopic Pancreatic Tumors in Mice
Published in Gastroenterology (New York, N.Y. 1943) (01-10-2014)“…Background & Aims The oncogene MDM2 , which encodes an E3 ubiquitin ligase, is overexpressed in pancreatic cancers and is therefore a therapeutic target…”
Get full text
Journal Article -
19
QSAR studies of new pyrido[3,4-b]indole derivatives as inhibitors of colon and pancreatic cancer cell proliferation
Published in Medicinal chemistry research (01-12-2018)“…We have discovered a new class of pyrido[ b ]bindole derivatives that show potent and broad spectrum anticancer activity with IC 50 values down to…”
Get full text
Journal Article -
20
Synthesis, docking, and biological studies of phenanthrene β-diketo acids as novel HIV-1 integrase inhibitors
Published in Bioorganic & medicinal chemistry letters (15-11-2013)“…In the present study we report the synthesis of halogen-substituted phenanthrene β-diketo acids as new HIV-1 integrase inhibitors. The target phenanthrenes…”
Get full text
Journal Article